Table 3.

Correlation between measures of metabolic dysregulation and background parenchymal enhancement, with and without adjustment for body mass index

	Without Adjustment for Body Mass Index		With Adjustment for Body Mass Index
Metabolic dysregulation	r	P	r	P
Fat mass	0.68	<0.001	0.05	0.69
Body fat	0.64	<0.001	0.08	0.56
Visceral adipose tissue	0.65	<0.001	0.12	0.38
Subcutaneous adipose tissue	0.60	<0.001	−0.21	0.12
Insulin	0.59	<0.001	0.23	0.097
Glucose	0.35	0.011	0.08	0.59
HOMA-IR	0.62	<0.001	0.26	0.062
Leptin	0.60	<0.001	0.08	0.58
Adiponectin	−0.44	<0.001	−0.12	0.37
CCL2	0.07	0.61	−0.08	0.58
IL-6	0.17	0.21	−0.15	0.30
IL-10	−0.01	0.96	−0.07	0.61
IL-12	−0.16	0.25	−0.21	0.13
TNF-a	0.10	0.46	−0.11	0.41
Total cholesterol	0.05	0.71	−0.01	0.96
Triglycerides	0.20	0.16	−0.13	0.36
Estrogen
Follicular	−0.05	0.69	−0.11	0.44
Luteal	−0.13	0.33	0.07	0.64
Progesterone
Follicular	−0.08	0.56	−0.01	0.99
Luteal	−0.17	0.22	0.17	0.22

HOMA-IR, homeostatic model of insulin resistance; CCL2, chemokine ligand 2; IL-6, interleukin-6; IL-10, interleukin-10; IL-12, interleukin-12; TNF-a, tumor necrosis factor-alpha.